Introduction
Superoxide dismutases (SODs) are an array of ubiquitous metalloenzymes in all oxygen-respiring organisms, which are essential enzymes that eliminate superoxide radicals (O
-
) and thus defend cells from being damaged by reactive oxygen species (ROS) [3, 30] . It is known that oxidative damage can peroxidize denatured proteins and unsaturated bonds of membrane lipids, and attack nucleic acids subsequently [43] . This mechanism may form the molecular basis of numerous diseases, such as cardiovascular alterations, the inflammation process, and carcinogenesis [10, 23, 43, 45] . SODs have been proved both clinically and preclinically to resist a number of diseases, such as myocardial oxidative damage, ischemic-reperfusion injury, thrombosis-related diseases, cancer, and inflammation [5, 8, 11, 21, 29, 38, 44] . Based on the metal cofactor in the active site and cellular localization, SOD can be identified and characterized by three distinct isoforms in mammals: Cu, ZnSOD, MnSOD, and ECSOD [36] . In the three distinct SOD isoforms, MnSOD is the unique SOD that has turned out to be key to the survival of organisms [4] . Hirudin is one of the most potent anticoagulant peptides (~7 kDa) ever found [28] . Hirudin can efficiently block the thrombin-mediated translation of fibrinogen into fibrin in the blood clotting reaction; therefore, it suppresses coagulation [17, 22] . Many researchers suggested that Hirudin is effective against many diseases, such as thrombosis-related diseases, kidney disease, cancer, and inflammation [1, 12, 18, 19, 27, 35] . Owing to the limited acquisition of natural Hirudin, numerous ways have been used since the 1990s to produce an abundant amount of recombinant Hirudin or its analog. The United States Food and Drug Administration has approved two Hirudin variants and a Hirudin analog to be marketed as anticoagulant drugs [13, 41] .
The ROS level, which is much higher in tumor cells in comparison with normal cells, is related to cancer survival, metastasis, development, and progression [9, 42] . Moroever, high levels of ROS may be beneficial to cancer proliferation and metastasis [37] . The ROS disruption, which cancer cells are more sensitive to compared with their normal counterparts, is often adopted in cancer therapy [7] . SODs are essential enzymes that eliminate superoxide radicals (O
) and catalyze a dismutation reaction that converts the superoxide radicals into O . Without SOD, superoxide radicals may initiate a radical chain reaction to give rise to other various ROS and in turn cause a number of pathologic processes. Tumor cells also generate lots of thrombin, which causes the formation of thrombosis. Studies have shown that the pro-coagulant activity of malignant cancer cells was closely associated with its metastatic potential. Thrombin, a tumor cell mitosis-promoting agent, not only promotes the metastatic phenotype of tumor cells by enhancing the proliferative response of cancer cells to epidermal growth factor, insulin, and transferrin, but also strengthens the tumorgenesis potential of healthy cells [40, 49] . The relationship between thrombosis and cancers has been well disclosed by platelet and fibrin deposition [14] . As evidenced by animal experiments, tumor growth and metastasis in vitro [49] and in vivo [32, 33] can be promoted by exogenous thrombin. The generation of host thrombin plays a significant role during tumor growth and spontaneous metastasis [19] . It is proposed that Hirudin, a highly potent and specific thrombin inhibitor, offers a promising anticarcinogenic effect, and therefore, the hMnSOD-Hirudin fusion protein may enhance synergies in cancer diseases via a DNA recombination technique.
Materials and Methods

Reagents
SmaI, DL, 2000 DNA Marker, Taq DNA Polymerase High Fidelity Kit, CIAP, T4 DNA ligase, protein marker, and DL 5000 DNA Marker were obtained from Takara (Japan). Isopropyl-β-Dthiogalactopyranoside (IPTG) and imidazole were obtained from Takara (China). E. coli strain Rosetta-gami was obtained from Novagen (Germany). Mouse anti-His monoclonal antibody and mouse anti-SOD2 monoclonal antibody were from Tiangen (China). Horseradish peroxidase (HRP)-labeled goat anti-mouse IgG was obtained from Proteintech (USA). Ni-NTA resin was obtained from Qiagen (Germany). The SOD activity assay kit, BCA kit, bovine fibrinogen, thrombin, and commercial hirudin were purchased from Biyuntian (China). The other agents applied in this work were of analytical grade or better.
Cell Culture
Human lung cancer 95-D cells, human kidney proximal tubular epithelial cells (HK-2), rat H9c2 cells, and human CD4+, T cells (H9) (Shanghai Cell Bank, China) were separately cultured in RPMI-1640 (Gibco, USA) and DMEM (Gibco) with the addition of 10% fetal bovine serum (Gibco), penicillin (100 U/ml), and streptomycin (100 mg/ml). The cells were grown in a 37°C incubator under 5% (v/v) CO
2
. Cells were subcultured every 2-3 days.
Construction of the Expression Vector
pET15b-hMnSOD was used as a template for the coding region of putative mature hMnSOD for PCR amplification. The PCR primers hMnSODFP (5' AAGCACAGCCTCCCCGACCT 3') and hMnSOD-linker-RP (5' GCTACCACCACCACCCTTTTTGCAAGC CAT GTATCTTT 3') were devised according to the sequence of hMnSOD gene (GenBank Accession ID: NM_000636.2). The procedures of PCR amplification were as follows: 95°C for 5 min; 32 cycles of 95°C for 30 sec, 60°C for 30 sec, and 72°C for 45 sec; and 72°C for 5 min. According to the amino acid sequence of Hirudin (GenBank Accession CAA02181.1), it has Leu, Pro, Thr, Gln, Lys, and Glu, which all exist in at least two codons. Based on the common codon of E. coli, we optimized those amino acid's codons to the common codon of E. coli. The rare codons changed to the common E. coli codons were used to improve the quantity of protein expression [25, 48] . The optimized Hirudin's nucleotide sequence and the PCR primers linker-HirudinFP (5' AAAAGG GTGGTGGTGGTAGCATGACCTACACCGACTGCACCGAA 3') and HirudinRP (5' TTCGGTGCAGTCGGTGTAGGTCAT 3') were synthesized by Invitrogen (China). (The underlined bases are the linker). The PCR products were identified with 1% agarose gel electrophoresis. Hirudin and hMnSOD genes were then connected with a polypeptide linker (GGGGS) by overlap-PCR for constructing the chain of hMnSOD-Hirudin fusion genes, using the PCR products of hMnSOD and Hirudin genes as the template with hMnSODFP and HirudinRP as primers.
The conditions of overlap-PCR amplification were as follows:
Step 1, 95°C for 5 min; 5 cycles of 95°C for 30 sec, 52°C for 30 sec, and 72°C for 45 sec; and 72°C for 7 min.
Step 2, add 2 μl hMnSODFP and 2 μl HirudinRP into the reaction products from step 1, then 95°C for 5 min; 32 cycles of 95°C for 30 sec, 52°C for 30 sec, and 72°C for 45 sec; and 72°C for 7 min. The overlapping PCR products were electrophoresed (1% agarose gel), and the band was excised and purified with a gel purification kit (Tiangen). The purified fragment of the hMnSOD-Hirudin gene was amplified by PCR amplification using the Pfu DNA Polymerase and linked into the pET15b (SmaI, CIAP) expression vector [47] . The pET15b-hMnSOD-Hirudin recombinant plasmid was verified by gene sequencing (Invitrogen), then transfected into E. coli strain Rosettagami.
Expression and Purification of the hMnSOD-Hirudin Protein
The E. coli Rosetta-gami strains containing pET15b-hMnSODHirudin recombinant plasmid were selected from a single strain colony and were grown overnight on an oscillator (37°C, 220 rpm) in 5 ml of Luria-Bertani (LB) medium supplemented with 100 μg/ml ampicillin. Then, a 2 ml culture mixture of strains was inoculated to 200 ml of fresh LB medium with 100 μg/ml ampicillin for continuous shaking culture, until the OD 6 0 0 value reached 0.4-0.6. It was then treated for a further 18 h (24°C, 220 rpm) with IPTG (0.6 mM) to induce hMnSOD-Hirudin fusion protein production. The bacteria were gathered by centrifugation (10 min, 5,000 ×g at 4°C) and then resuspended in bacterial lysate (1 mM PMSF, 10 mg/ml Lysozyme, 25 mM NaCl, 20 mM Tris-HCl, pH 7.4, and 0.1% Triton X-100). The bacteria were then sonicated for cell breakage (50 short bursts, about 6 sec each, keeping the bacterial suspension cool on ice during each burst). The lysates were centrifuged at 4°C (20,800 ×g, 15 min). The supernatant and precipitate were analyzed by SDS-PAGE on 12% gels according to Laemmli [24] . The supernatant was filtered out and purified by Ni-NTA affinity chromatography (Ni-NTA AC) according to the Qiagen manual.
The fusion protein was eluted and purified via rising the imidazole concentration (30-300 mM) [26] . To remove the imidazole, the purified hMnSOD-Hirudin fusion protein was dialyzed with dialysate (20 mM sodium phosphate, 500 mM NaCl, 10% glycerol, pH 7.4) overnight [47] .
Western Blot Analysis
The clarified supernatants were subjected to 12% SDS-PAGE, then electroblotting onto a PVDF membrane under a 200 V electric current for a 40 min duration. The membrane was then blocked with blocking reagent (Tris-buffered saline, 0.1% Tween 20, and 5% non-fat milk) at 4°C overnight. The blocked PVDF membrane was rinsed in TBST (four times, 5 min each). One group was hybridized with mouse anti-His IgG (diluted to 1:1,000) and another group was incubated with mouse anti-SOD2 IgG (diluted to 1:1,000) for 2 h at 25°C. The PVDF membranes were then washed in TBST (three times, 15 min each) and incubated with HRP-labeled goat anti-mouse IgG (diluted to 1:4,000) at 37°C for 1 h. The PVDF membrane was then rinsed three times with TBST, visualized by enhanced chemiluminescence with detection reagent, and then exposed to an autoradiography film.
Assay of Protein Concentration and Activity of the hMnSODHirudin Protein
The BCA method was used to determine the concentration of hMnSOD-Hirudin fusion protein; bovine serum albumin was used as the standard.
The hMnSOD-Hirudin fusion protein was then divided into a series of groups (200 μl of 32 nM/ml of the hMnSOD-Hirudin protein each group). One group was left intact and the other group was respectively treated with numbers of equimolar metal ions (Fe ) [31] . The SOD activity assay kit was utilized to assay the antioxidation activity of the recombinant hMnSOD-Hirudin protein (Jiancheng, China). The determination was based on the inhibitory effect of the enzyme on the oxidation of hydroxylamine catalyzed by the xanthine-xanthine oxidase system [34] . One unit of antioxidation activity was defined as the quantity of SOD that inhibited 50% of the oxidation of pyrogallol and it was represented as U/mg protein. The diluted bovine Cu/Zn SOD (1,000 U/ml) purchased from Sigma was adopted as the standards, equimolar intact hMnSOD and Mn
+
were used as the positive control, and 0.01 M phosphate-buffered saline (PBS, pH = 7.4) was used as the negative control. Anticoagulant activity of the hMnSOD-Hirudin protein was measured with the thrombin titration method. The anticoagulant activity of the test samples was determined based on its thrombin neutralizing activity and represented as antithrombin unit (ATU). The sample that neutralizes one NIH unit of thrombin is equal to 1 ATU [20] . Commercial rHirudin (diluted to 500 ATU/ml) was used as the standard, equimolar intact Hirudin was used as the positive control, and 0.01 M PBS (pH = 7.4) was used as the negative control.
DNA Oxidation Damage Protective Assay of the hMnSOD-Hirudin Protein
DNA oxidation damage protective activity of the hMnSODHirudin protein was proved using supercoiled pUC-19 DNA. The hMnSOD-Hirudin protein (0-5 nM/ml) was incubated with 5 μl of DNA (0.5 μg) in a total volume of 10 μl for 10 min at room temperature. Then, 10 μl of Fenton's reagent (80 μM FeCl ) was added to the mixture of the hMnSOD-Hirudin protein and pUC-19 DNA. The mixture was incubated at 37°C for 30 min, and subsequently analyzed by 0.8% agarose gel electrophoresis [46] .
MTT Cytotoxicity Assay
The H9c2 cells, HK-2 cells, and H9 cells were grown for 24 h and then incubated with the hMnSOD-Hirudin fusion protein at serial concentrations (0, 20, 40, 60, 80, and 100 μg/ml) for 24 h. Then, the growth inhibitory effect of the hMnSOD-Hirudin protein toward the H9c2 cells, HK-2 cells, and H9 cells was evaluated by MTT assay [6] . Equal mass concentrations of cisdiamminedichloroplatinum were used as the positive control.
Cell Migration and Invasion Assays
The 95-D cells were separately incubated with the hMnSODHirudin (2.5 and 5 nM/ml), hMnSOD (2.5 nM/ml), and Hirudin protein (2. 
Statistical Analysis
All treatments were duplicated 3 times. Experimental data were expressed as the mean ± SEM. Statistical analyses were subjected to one-way ANOVA followed by the Newman-Keuls multiple comparison test to valuate statistical significance, and p < 0.05 was considered significant.
Results
Cloning of the hMnSOD-Hirudin Gene and Construction of the Expression Vector
The hMnSOD-Hirudin gene fragment contained an 807 bp open reading frame and ended with the stop codon TGA (Fig. S1A ). It encodes a putative 269 amino acid protein with an estimated molecular mass of about 30 kDa and a pI equal to 5.53. The hMnSOD, Hirudin, and recombination of hMnSOD-Hirudin gene PCR products were characterized by 1% agarose gel electrophoresis (Fig. S1B) . The recombinant plasmid was identified by 1% agarose gel electrophoresis (Fig. S1C ) and verified by gene sequencing. Sequence analysis showed that the fragment of the hMnSOD-Hirudin gene was successfully inserted in-frame to the upper stream of the vector-derived His-tag coding sequence (Fig. S1D) . The pET15b-hMnSOD-Hirudin recombinant plasmid construct was supposed to be able to express the hMnSOD-Hirudin fusion protein with a His-tag. With this His-tag, the expressed hMnSOD-Hirudin fusion protein could be easily purified by Ni-NTA AC.
Expression and Purification of Recombinant hMnSODHirudin Protein
After induction with IPTG, E. coli strain Rosetta-gami transformed with pET15b-hMnSOD-Hirudin recombinant plasmid expressed a fusion protein of about 30 kDa (His6-tagged hMnSOD-Hirudin protein) as shown in (Fig. 1A) . After a series of expression condition optimizations, the optimal expression of hMnSOD-Hirudin fusion protein in soluble type was observed by induction with 0.6 mM IPTG at 22°C for 20 h. The expressed hMnSOD-Hirudin in soluble form immensely helped its purification. Ni-NTA AC was applied to purify the expressed fusion protein. The SDS-PAGE gel showed that the hMnSOD-Hirudin fusion protein appeared as nearly a single band of approximately 30 kDa after Ni-NTA AC purification (Fig. 1B) . The hMnSODHirudin protein was verified by western blotting with anti-SOD2 and anti-His antibodies (Fig. 1C) . The final expression quantity of the hMnSOD-Hirudin protein was approximately 67.25 mg/l of cultures.
Protein Concentration and Enzyme Activity
The BCA method indicated that the hMnSOD-Hirudin protein concentration reached 3.42 mg/ml. To determine the activity of hMnSOD-Hirudin protein and the influences of metal ions on the antioxidation activity of the hMnSODHirudin protein, the hMnSOD-Hirudin protein was respectively treated with diverse equimolar metal ions (Na group showed a higher antioxidation activity, but there was almost no significant difference in antioxidation activity among the other groups ( Fig. 2A) . However, there was no significant difference in anticoagulant activity among all groups (Fig. 2B) . Thus, the highest antioxidation activity of the hMnSOD-Hirudin protein obtained was 2,444.0 ± 96.0 U/ml (about 2,444.0 ± 96.0 U/mg), and the anticoagulant activity of the hMnSOD-Hirudin protein was 599.0 ± 35.0 ATU/ml (about 599.0 ± 35.0 ATU/mg).
DNA Protection Activity of the hMnSOD-Hirudin Protein
The agarose gel results showed that the pUC-19 native plasmid DNA without pre-incubation with the hMnSODHirudin protein was almost entirely damaged by Fenton's reagent. Meanwhile, as hMnSOD-Hirudin's dose increased, the Fenton's reagent damage to the nicked DNA bands was abated. As a result, the supercoiled DNA bands increased and exhibited dose-dependency. The pUC-19 DNA was almost not damaged by Fenton's reagent and was extremely close to the natural pUC-19 DNA when the hMnSODHirudin protein concentration reached 5 nM/ml (Fig. 3) . The intact hMnSOD protein and the intact Hirudin protein were used as controls. The result suggested that the hMnSOD-Hirudin protein has excellent DNA protection activity.
No Cytotoxicity of the hMnSOD-Hirudin Protein in H9c2, HK-2, and H9 Cell Lines MTT assay results indicated that 0-100 µg/ml hMnSODHirudin protein exhibited no or little cell toxicity in the H9c2, human HK-2, and H9 cell lines; the cell viability had no significant difference with the control group (Fig. 4) .
hMnSOD-Hirudin Protein Suppresses Cancer 95-D Cell Invasion and Metastasis In Vitro
The changes of the invasive and migratory abilities of the 95-D cells were detected by transwell invasion assay and migration assay after being incubated with 5 nM/ml hMnSOD, Hirudin, hMnSOD + Hirudin, and hMnSODHirudin protein, respectively. The migratory ability of 95-D cells respectively decreased about 24%, 26%, 28%, and 48%. Compared with the 2.5 nM/ml hMnSOD-Hirudin group and the 5 nM/ml hMnSOD + Hirudin group, the migratory ability of 95-D cells of the 5 nM/ml hMnSODHirudin group respectively decreased about 34% and 32%. (Fig. 5A) , and the invasive ability of 95-D cells respectively decreased about 22%, 24%, 30%, and 49%. Compared with the 2.5 nM/ml hMnSOD-Hirudin group and the 5 nM/ml hMnSOD + Hirudin group, the invasion ability of 95-D cells of the 5 nM/ml hMnSOD-Hirudin Significantly impeded abilities of cell migration (A) and invasion (B) in 95-D cells after being incubated with the hMnSOD-Hirudin (2.5 and 5 nM/ml), hMnSOD (2.5 nM/ml), and Hirudin protein (2.5 nM/ml) and phosphate-buffered saline (0.01 M, pH = 7.4). Results are expressed as the mean ± SD of three independent experiments. Statistically and highly significant differences from the control in each group are indicated as *p < 0.05, **p < 0.01, and ***p < 0.001, respectively.
group respectively decreased about 36% and 31%. (Fig. 5B) .
Discussion
Using DNA recombination techniques, we can make different genes or gene fragments fuse together. Then, by piecing different functional proteins together after the expression, we can acquire artificial proteins with new multi-domains. This method has been widely used in the study of many fields, and it has shown to be of high value in targeted drug design or in the production of new cytokines. The linker sequence of the two macromolecules is important for the construction and function of the fusion proteins. According to Robinson and Sauer's [39] research, the folding stability of a fusion protein is heavily associated with the linker sequence composition. We designed a GGGGS linker sequence based on the literature of Arai et al. [2] and Gustavsson et al. [16] . Our enzyme activity results of the hMnSOD-Hirudin fusion protein indicate that each domain worked independently even after the spatial isolation of the double-functional domains (connected via GGGGS linker peptide). Recombinant pET15b-hMnSODHirudin plasmid was expressed in the Rosetta-gami strain of E. coli at a high level as a soluble form and purified via Ni-NTA affinity chromatography purification. Our results indicate that the Rosetta-gami E. coli production system is suitable for high-level expression of the hMnSOD-Hirudin protein.
The results indicated not only that the hMnSOD-Hirudin protein has outstanding antioxidation activity but also excellent anticoagulant activity. The metal ion effect on the activity of the hMnSOD-Hirudin protein results showed that the antioxidation activity was activated significantly by Mn 2 + , but the metal ions did not affect the anticoagulant activity. ROS elimination is a usually recognized mechanism of antioxidants inhibiting oxidative DNA lesion. The hMnSOD-Hirudin protein proved to be efficient in safeguarding oxidative DNA lesion. Furthermore, an assay of bioactivity in vitro showed that the hMnSOD-Hirudin protein would not suppress the proliferation of H9c2, HK-2, and H9 cells, and showed little to no cytotoxicity in these three cell lines. Cell migration and invasion are the major features of metastatic tumor cells responsible for most cancer-related deaths [15] . Compared with the control group, transwell migration and invasion assays showed that the hMnSOD protein group, Hirudin protein group, the mixture of hMnSOD and hirudin protein group, as well as the hMnSOD-Hirudin protein group all could significantly suppress 95-D human lung tumor cell line invasion and metastasis in vitro, and the equimolar hMnSOD-Hirudin protein had the best effects on suppressing 95-D human lung cancer cell metastasis and invasion. Besides this, with the increasing concentration of hMnSOD-Hirudin, the ability of hMnSOD-Hirudin to suppress 95-D human lung cancer cell metastasis and invasion was more powerful. The hMnSOD-Hirudin fusion protein exhibited a synergistic effect, compared with either hMnSOD or Hirudin, as this is probably due to the fact that it possesses two catalytic domains. Interestingly, compared with the mixture of hMnSOD and hirudin group, the hMnSOD-Hirudin fusion protein exhibited a better synergistic effect. We speculated that the higher molecular weight of hMnSOD-Hirudin fusion protein could partially account for this result. It could also be that Hirudin is a specific depressor of thrombin, which can target thrombin and lead to a higher level of local hMnSOD-Hirudin fusion protein concentration, but the real reason requires further experimental inquiry and verification. It was suggested that both the MnSOD and Hirudin proteins may have therapeutic benefits toward many diseases, including thrombosis-related diseases, inflammation, and cancer. The synergistic effect of the hMnSOD-Hirudin fusion protein may provide enhanced therapeutic effects in thrombotic diseases, inflammation, and cancer. A stable and purified form of the hMnSODHirudin protein is necessary for further studies. Our work will facilitate further in vivo and in vitro study of hMnSOD-Hirudin's resistance and novel therapy towards thrombotic diseases, inflammation, and cancer.
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